# NHS Framework for the North of England, Branded Medicines - Tranche B, Annual Tranche and Insulin Aspart Biosimilar \(Trurapi®\)

> Tender notice from UK public-sector procurement sources.

## Key facts

- Public buyer: [NHS England](/buyers/nhs-england/contract-awards)
- Tender value: £431,955,441
- Published: 15 September 2021
- Planned start: 1 March 2022
- Planned end: 29 February 2024
- Stage: open_tender
- Procurement category: goods
- Notice ID: 5c1bba5d-fde4-49c3-bbaa-f6d81ffafe25-468848
- OCID: ocds-b5fd17-8a4d60cd-d6cc-4e83-9f3c-6153cf0bb97a

## Description

Offer reference number: CM/PHR/20/5600 CM/PHR/20/5600/01 - NHS Framework for the North of England, Branded Medicines -Tranche B - 1 March 2022 to 29 February 2024 with an option or options to extend \(at the Authority's discretion\) for a period or periods up to a total of 24 months CM/PHR/20/5600/02 - NHS Framework for the North of England, Branded Medicines - Annual Tranche Products\. Period of framework: 1 March 2022 to 28 February 2023 with an option or options to extend \(at the Authority's discretion\) for a period or periods up to a total of 12 months\. CM/PHR/20/5600/03- NHS Framework for Insulin Aspart Biosimilar \(Trurapi®\), South of England - Period of framework: 1 March 2022 to 31 August 2022 with an option or options to extend \(at the Authority's discretion\) for a period or periods up to a total of 12 months\. CM/PHR/20/5600/04 - NHS Framework for Insulin Aspart Biosimilar \(Trurapi®\), London - Period of framework: 1 March 2022 to 31 August 2023 with an option or options to extend \(at the Authority's discretion\) for a period or periods up to a total of 24 months\. CM/PHR/20/5600/05 - NHS Framework for Insulin Aspart Biosimilar \(Trurapi®\), Midlands and East - Period of framework: 1 March 2022 to 28 February 2023 with an option or options to extend \(at the Authority's discretion\) for a period or periods up to a total of 24 months\.

## Related contract awards

- [Transformation Delivery Services - Establishing Operational Excellence \(EOE\)](/contracts/ocds-b5fd17-b08595d2-8961-409b-9b62-7b01d7a64541): NHS England
- [Identity Access Management - Service Adoption and Enablement](/contracts/ocds-b5fd17-08ebad6c-84fb-4e62-9afd-d06d220dd3a5): NHS England
- [OutSystems licenses for MAPPTI \(AP&P\)](/contracts/ocds-b5fd17-521fbf90-6e93-4366-b3bc-47aa2efd447d): NHS England

## Source

[View the original notice on Contracts Finder](https://www.contractsfinder.service.gov.uk/Notice/5c1bba5d-fde4-49c3-bbaa-f6d81ffafe25-468848)